484 related articles for article (PubMed ID: 25322151)
1. Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity.
Kosmaczewska A
Int J Mol Sci; 2014 Oct; 15(10):18574-92. PubMed ID: 25322151
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
Astry B; Venkatesha SH; Moudgil KD
Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases.
Graßhoff H; Comdühr S; Monne LR; Müller A; Lamprecht P; Riemekasten G; Humrich JY
Front Immunol; 2021; 12():648408. PubMed ID: 33868284
[TBL] [Abstract][Full Text] [Related]
4. The deviated balance between regulatory T cell and Th17 in autoimmunity.
Jadidi-Niaragh F; Mirshafiey A
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):727-39. PubMed ID: 22316060
[TBL] [Abstract][Full Text] [Related]
5. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
[TBL] [Abstract][Full Text] [Related]
6. Low-dose IL-2 therapy in autoimmune diseases: An update review.
Zhang R; Zhao Y; Chen X; Zhuang Z; Li X; Shen E
Int Rev Immunol; 2024 May; 43(3):113-137. PubMed ID: 37882232
[TBL] [Abstract][Full Text] [Related]
7. The Potential of Harnessing IL-2-Mediated Immunosuppression to Prevent Pathogenic B Cell Responses.
Papillion A; Ballesteros-Tato A
Front Immunol; 2021; 12():667342. PubMed ID: 33986755
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the interleukin-6 signaling pathway: a strategy to induce immune tolerance.
Zhang C; Zhang X; Chen XH
Clin Rev Allergy Immunol; 2014 Oct; 47(2):163-73. PubMed ID: 24647663
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and lymphopenia trigger autoimmunity by suppression of IL-2-controlled regulatory T cell and increase of IL-21-mediated effector T cell expansion.
Chevalier N; Thorburn AN; Macia L; Tan J; Juglair L; Yagita H; Yu D; Hansbro PM; Mackay CR
J Immunol; 2014 Nov; 193(10):4845-58. PubMed ID: 25339665
[TBL] [Abstract][Full Text] [Related]
10. Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases.
Ballesteros-Tato A
Immunotherapy; 2014; 6(11):1207-20. PubMed ID: 25496335
[TBL] [Abstract][Full Text] [Related]
11. Low-dose Interleukin-2: Biology and therapeutic prospects in rheumatoid arthritis.
Wu R; Li N; Zhao X; Ding T; Xue H; Gao C; Li X; Wang C
Autoimmun Rev; 2020 Oct; 19(10):102645. PubMed ID: 32801037
[TBL] [Abstract][Full Text] [Related]
12. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
Stadhouders R; Lubberts E; Hendriks RW
J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
[TBL] [Abstract][Full Text] [Related]
13. The role of FOXP3
Mohr A; Atif M; Balderas R; Gorochov G; Miyara M
Clin Exp Immunol; 2019 Jul; 197(1):24-35. PubMed ID: 30830965
[TBL] [Abstract][Full Text] [Related]
14. IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells.
Du R; Zhao H; Yan F; Li H
J Leukoc Biol; 2014 Jul; 96(1):39-48. PubMed ID: 24744433
[TBL] [Abstract][Full Text] [Related]
15. T helper 17 cells in autoimmune liver diseases.
Abe M; Hiasa Y; Onji M
Clin Dev Immunol; 2013; 2013():607073. PubMed ID: 24223606
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-mediated regulation of T helper type 17/regulatory T-cell balance in autoimmune disease.
Liu C; Yang H; Shi W; Wang T; Ruan Q
Immunology; 2018 Dec; 155(4):427-434. PubMed ID: 30133700
[TBL] [Abstract][Full Text] [Related]
17. When worlds collide: Th17 and Treg cells in cancer and autoimmunity.
Knochelmann HM; Dwyer CJ; Bailey SR; Amaya SM; Elston DM; Mazza-McCrann JM; Paulos CM
Cell Mol Immunol; 2018 May; 15(5):458-469. PubMed ID: 29563615
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
Fasching P; Stradner M; Graninger W; Dejaco C; Fessler J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28098832
[TBL] [Abstract][Full Text] [Related]
19. The role of regulatory T Cells in autoimmune orchitis.
Jacobo P
Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
[TBL] [Abstract][Full Text] [Related]
20. Potential route of Th17/T
Karri SK; Sheela A
Br J Biomed Sci; 2017 Jan; 74(1):8-15. PubMed ID: 28074676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
